Karen T Toledo, OD
Optometry · Fontana
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Southern California Permanente Medical Group · 11,250 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Toledo’s office to ask if they take your plan before you enroll.
Medicaid work
$20,949 in 2024
Medicaid paid $20,949 for 1,161 billed services this clinician did in 2024, up to 61 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 162 | $12,456 |
| DETERMINATION REFRACTIVE STATE | 422 | $4,496 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 67 | $2,493 |
| INTRM OPH EXAM NEW PATIENT | 51 | $1,504 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 99 | $0 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 91 | $0 |
| Frames, purchases | 184 | $0 |
| Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 25 | $0 |
| Mirror coating, any type, solid, gradient or equal, any lens material, per lens | 60 | $0 |
| 2024 | 1,161 | 9 | 61 | $20,949 |
| 2023 | 1,121 | 9 | 50 | $5,899 |
| 2022 | 926 | 5 | 40 | $8,564 |
| 2021 | 342 | 5 | 31 | $1,539 |
See the largest Medicaid services in earlier years
2023
| Frames, purchases | 249 | $2,185 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 125 | $1,385 |
| Fitting of monofocal spectacles | 78 | $690 |
| DETERMINATION REFRACTIVE STATE | 424 | $604 |
| Fitting of bifocal spectacles | 41 | $401 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 19 | $320 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 143 | $316 |
| INTRM OPH EXAM NEW PATIENT | 27 | $0 |
| Mirror coating, any type, solid, gradient or equal, any lens material, per lens | 15 | $0 |
2022
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 215 | $3,573 |
| Frames, purchases | 202 | $1,669 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 77 | $1,456 |
| DETERMINATION REFRACTIVE STATE | 351 | $1,363 |
| Fitting of monofocal spectacles | 81 | $504 |
2021
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 65 | $604 |
| Frames, purchases | 84 | $307 |
| DETERMINATION REFRACTIVE STATE | 133 | $303 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 32 | $249 |
| Fitting of monofocal spectacles | 28 | $78 |
Drugs they prescribed that Part D paid
$34,311
Pharmacies billed $34,311 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 251) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
118 generic and 133 brand-name prescriptions · $34,311 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cyclosporine | 68 | $15,606 | $230 |
| Restasis | 14 | $8,851 | $632 |
| Fluorometholone | 11 | $1,366 | $124 |
| Brimonidine | 13 | $1,187 | $91 |
| Prednisolone Acetate | 16 | $642 | $40 |
See all 8 drugs
| Cyclosporine | 68 | $15,606 | $230 |
| Restasis | 14 | $8,851 | $632 |
| Fluorometholone | 11 | $1,366 | $124 |
| Brimonidine | 13 | $1,187 | $91 |
| Prednisolone Acetate | 16 | $642 | $40 |
| Latanoprost | 46 | $599 | $13 |
| Dorzolamide-Timolol | 22 | $475 | $22 |
| Azelastine | 13 | $129 | $10 |
Year by year
| 2024 | 251 | 143 | 0% (0) | 53% | $34,311 |
| 2023 | 1,280 | 374 | 0% (0) | 46% | $395,002 |
| 2022 | 1,316 | 365 | 0% (0) | None | $990,328 |
| 2021 | 674 | 231 | 0% (0) | 45% | $85,230 |
| 2020 | 11 | None | 0% (0) | None | $4,017 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Restasis | 104 | $113,899 | $1,095 |
| Cyclosporine | 98 | $62,873 | $642 |
| Xiidra | 31 | $42,453 | $1,369 |
| Rhopressa | 13 | $9,407 | $724 |
| Latanoprost | 368 | $9,276 | $25 |
| Lumigan | 17 | $9,123 | $537 |
| Brimonidine | 88 | $6,791 | $77 |
| Alphagan P | 18 | $5,129 | $285 |
| Dorzolamide-Timolol | 173 | $4,630 | $27 |
| Brimonidine Tartrate-Timolol | 13 | $2,283 | $176 |
| Dorzolamide | 60 | $1,806 | $30 |
| Timolol Maleate | 86 | $1,797 | $21 |
| Azelastine | 54 | $1,595 | $30 |
| Prednisolone Acetate | 21 | $949 | $45 |
| Erythromycin | 13 | $161 | $12 |
| Neomycin-Polymyxin-Dexameth | 11 | $154 | $14 |
2022: 18 drugs
| Tepezza | 14 | $755,144 | $53,939 |
| Restasis | 105 | $124,086 | $1,182 |
| Cyclosporine | 21 | $13,064 | $622 |
| Rhopressa | 22 | $12,918 | $587 |
| Restasis Multidose | 15 | $12,190 | $813 |
| Lumigan | 27 | $9,426 | $349 |
| Latanoprost | 434 | $8,588 | $20 |
| Brimonidine | 121 | $7,024 | $58 |
| Alphagan P | 16 | $6,848 | $428 |
| Dorzolamide-Timolol | 143 | $3,339 | $23 |
| Prednisolone Acetate | 46 | $2,351 | $51 |
| Dorzolamide | 73 | $2,184 | $30 |
| Timolol Maleate | 66 | $972 | $15 |
| Moxifloxacin | 14 | $865 | $62 |
| Azelastine | 20 | $786 | $39 |
| Ketorolac Tromethamine | 17 | $309 | $18 |
| Neomycin-Polymyxin-Dexameth | 17 | $300 | $18 |
| Erythromycin | 25 | $265 | $11 |
2021: 15 drugs
| Restasis | 34 | $32,884 | $967 |
| Restasis Multidose | 12 | $8,681 | $723 |
| Lumigan | 19 | $7,746 | $408 |
| Rhopressa | 11 | $5,679 | $516 |
| Latanoprost | 206 | $5,025 | $24 |
| Dorzolamide-Timolol | 74 | $2,326 | $31 |
| Brimonidine | 30 | $1,800 | $60 |
| Prednisolone Acetate | 40 | $1,722 | $43 |
| Dorzolamide | 55 | $1,388 | $25 |
| Olopatadine | 19 | $890 | $47 |
| Tobramycin-Dexamethasone | 12 | $834 | $69 |
| Ketorolac Tromethamine | 24 | $523 | $22 |
| Azelastine | 15 | $455 | $30 |
| Timolol Maleate | 27 | $438 | $16 |
| Neomycin-Polymyxin-Dexameth | 14 | $244 | $17 |
Money from drug and device companies
$46 in 2023
| 2023 | 1 | 2 | None | $46 |
| 2022 | 5 | 5 | None | $285 |
| 2021 | 4 | 14 | None | $434 |
| 2019 | 1 | 1 | None | $87 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Horizon Therapeutics plc | Tepezza | $46 | 2 payments
|
See all 2 published payments
| Horizon Therapeutics plc | Meals · 2023-04-25 | Tepezza | $29 |
| Horizon Therapeutics plc | Meals · 2023-01-05 | Tepezza | $17 |
See earlier years (2022, 2021, 2019)
2022: $285
| Kala Pharmaceuticals | Eysuvis | $125 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $87 | 1 payment
|
| Regeneron Healthcare Solutions | Eylea | $33 | 1 payment
|
| BioTissue Holdings | Prokera | $23 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $17 | 1 payment
|
2021: $434
| Aerie Pharmaceuticals | Rocklatan | $190 | 11 payments
|
| Ivantis | Hydrus Microstent | $135 | 1 payment
|
| Synergeyes | Duette Contact Lenses | $87 | 1 payment
|
| Allergan | Restasis Multidose | $22 | 1 payment
|
2019: $87
| Carl Zeiss Meditec | Cirrus Hd-Oct | $87 | 1 payment
|
Professional record
- NPI
- 1851942569
- Licence
- CA 34380TLG
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 8028 3rd St, Downey, CA, 90241
- NPI first listed
- 2019-09-24
- NPI last updated
- 2024-01-18
- NPI record certified
- 2024-01-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 8028 3rd St, Downey, CA, 90241 · 3801 Miranda Ave, Palo Alto, CA, 94304
This office lists an electronic records connection.